News

Sprycel (dasatinib) is the first approved oral tyrosine kinase inhibitor predicted to bind to multiple conformations of the ABL kinase based on modeling studies. The drug's effectiveness is

Wyeth is seeking marketing approval for Lybrel, an investigational low dose combination oral contraceptive for women have no known contraindications for this method of contraception. If approved, this

Therion announced that the 255-patient trial did not meet its primary efficacy endpoint of improving overall survival compared with palliative chemotherapy or best supportive care, and said that

This agreement follows the successful completion of an exploratory study performed with the MicroDose dry powder inhaler (DPI). Under the terms of the agreement, including the initial payment,

Genoptix is known for its focus on providing high-quality and personalized clinical esoteric services to hematologists/oncologists, which aid in the evaluation and management of hematomalignancies. In addition, Genoptix

The trial is a multi-center 1,200-patient study in the first-line treatment of patients with metastatic colorectal cancer. Patients will be equally randomized to two arms containing either CoFactor

Abraxis will have agreements with most major group purchasing organizations, representing the majority of US hospitals, and will assume responsibility for over 700 individual contracts for this portfolio

In October 2004, Angiotech's surgical specialties division and Quill entered into an exclusive manufacturing and distribution agreement for the Contour Threads product line to be used in minimally-invasive

Chimerix will initiate a single-site phase I clinical trial to evaluate the safety of CMX001 in healthy volunteers. CMX001 is an oral antiviral drug candidate to be evaluated